calibrate glp-1 program pricing 2025 Weight-Loss Clinic Review: Sustainable Care Calibrate Online GLP-1 Clinic Review

Early clinical results suggest the treatment is safe and well tolerated.

Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes

Amongst, overweight and obese patients defined by BMI in 2024 (58.9% [95% CIs 53.3-64.2%] female [182/309], median [IQR] age 56.6 [46.2-66.1]) GLP 1RA use has increased from 3.2% (10/309 [95% CIs 1.8-5.9%]) to 13.6% (42/309 [95% CIs 10.2-17.9%] [p=7.1x10-6])

For local players, this reinforces the role of licensing and distribution alliances as a practical path to compete in the global #obesity market ahead of full-scale innovation or manufacturing build-out

Advanced Prebiotic Technology PreforPro bacteriophage technology provides selective microbiome support, working alongside traditional prebiotics to promote beneficial bacteria without adding fermentable fibers that can trigger bloating

Calibrate and Found both offer telehealth-based GLP-1 weight loss programs, but differ in medication access, provider involvement, pricing, and support structures